Semax COA: Three Molecules Ship Under One Name

For research use only. Not for human or animal consumption.


What it is

Semax is a synthetic heptapeptide: Met-Glu-His-Phe-Pro-Gly-Pro (MEHFPGP). The first four residues reproduce positions 4–7 of the N-terminal region of adrenocorticotropic hormone (ACTH). The C-terminal Pro-Gly-Pro tripeptide is a synthetic addition, not part of the native ACTH sequence.

The identity block a genuine vial should match:

  • Chemical name: Semax (Met-Glu-His-Phe-Pro-Gly-Pro; ACTH(4-7)PGP)
  • CAS number: 80714-61-0
  • Molecular formula: C37H51N9O10S
  • Molecular weight: 813.93
  • Form: lyophilised (freeze-dried) powder
  • Storage: −20°C, desiccated, protected from light

The single sulfur atom in that formula is the methionine side chain at position 1 — a residue that matters later, because methionine oxidises.

One naming note before anything else. The literature describes this molecule two ways — as “an ACTH(4-10) analogue” and as “ACTH(4-7)PGP” — and those are one compound, not two. But ACTH(4-10) is literally Met-Glu-His-Phe-Arg-Trp-Gly, which Semax is not. A buyer checking a certificate against the literal ACTH(4-10) string sees a mismatch, then either rejects correct material or accepts something else entirely.

What researchers are studying

The record cited here is preclinical: rodent in vivo work plus a few solution-chemistry and cell-line studies. Nothing in it establishes what the molecule does in a person. What follows describes what was examined, and in which model.

  • Binding-site characterisation. Membranes from rat basal forebrain were tested for specific binding of tritium-labelled Semax. Binding was reported as time-dependent, specific, reversible and calcium-dependent, with a dissociation constant of 2.4 ± 1.0 nM and a Bmax of 33.5 ± 7.9 fmol/mg protein. The same study assayed BDNF protein in basal forebrain and cerebellum. [1]
  • Neurotrophin transcripts and protein in rodent brain tissue. A rat study measured BDNF protein, trkB tyrosine phosphorylation, and exon III BDNF and trkB mRNA in the hippocampus after a single application at the amount and by the route described in the paper: a maximal 1.4-fold change at the protein level, 3-fold and 2-fold changes in the two mRNA measures. [2]
  • Transcriptome surveys in rodent cerebral ischemia models. A microarray study profiled ischemized rat cortex 3 h and 24 h after permanent middle cerebral artery occlusion, sorting differentially expressed transcripts by annotation into immune groupings (immunoglobulin and chemokine genes largest) and vascular groupings — 24 genes at 3 h, 12 at 24 h. [3] A later RNA-Seq study used the transient occlusion model and found 394 differentially expressed genes above a 1.5-fold threshold at 24 h. [4]
  • Coordination chemistry. An Italian CNR group characterised, in solution and in an SH-SY5Y neuroblastoma line, how acetylating the N-terminal amino group changed the copper(II) complex formed: a distorted CuN3O chromophore with weak apical methionine-sulfur interaction for the acetylated form, against a CuN4 chromophore for the free-amine parent, with a more positive formal redox potential. Zinc(II) complexation and cellular Zn(II) influx were also compared. [5]
  • Monoamine neurochemistry in rodents. Tissue and extracellular striatal concentrations of dopamine, its metabolites, and the serotonin metabolite 5-HIAA were measured in rodents at intervals across the time course described in the paper, alongside locomotor measures. [6]

What the record does not settle. The corpus is concentrated in authorship: four of the six papers cited here come from the Institute of Molecular Genetics of the Russian Academy of Sciences and associated Moscow institutions, often with the same senior authors. Independent replication outside that network is sparse, the mechanistic work is descriptive, and sample sizes are small.

How to verify a vial of Semax before you pay

Semax carries a sourcing problem most peptides do not. Three distinct chemical entities ship under that one word:

  1. Base Semax — free N-terminal amine, C37H51N9O10S, 813.93.
  2. N-acetyl Semax — acetylated N-terminus, roughly +42 Da.
  3. N-acetyl Semax amidate — acetylated N-terminus plus C-terminal amide.

A label reading “Semax” does not distinguish them, and neither does a purity figure. Purity states how much of the material is a single species; it does not state which species. Only the mass-spectrometry trace on that lot’s certificate answers that, by putting the observed molecular ion against the 813.93 expected for the free-amine form. Magrì et al. reported the free NH2 terminus as the determining feature in their neuroblastoma cell system. [5] A buyer who receives the wrong form has a different test article, not a variant of the same one.

Three further traps, all resolved by the same document:

  • Labelled milligrams are not peptide milligrams. Semax is commonly supplied as an acetate salt, so the lyophilised mass includes counterion and residual water. Net peptide content is a separate determination from chromatographic purity, and no volume of solvent used to dissolve the powder can resolve it — the ambiguity is in the powder, not the solvent.
  • Fragment matches prove nothing. Semax shares its C-terminal Pro-Gly-Pro with Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro, CAS 129954-34-3), routinely sold alongside it. Free PGP is also a plausible fragment of an incompletely intact lot.
  • Methionine oxidises. Methionine sulfoxide is a +16 Da species — visible in the mass data, invisible in a single purity number.

The drill that settles all four questions is document-based, and takes about a minute:

  1. A named third-party laboratory. The certificate should name an outside lab, not the seller’s own bench. Clarion’s current Semax lot was analysed by Freedom Diagnostics Testing. Clarion uses more than one third-party laboratory, assigned per lot, so the question is always which lab is named on that lot’s certificate.
  2. A lot number that matches the vial. The lot you received must resolve, through the public lot ledger, to that lot’s own signed certificate. A report for another batch says nothing about the vial in hand.
  3. Both assays, figures printed. HPLC for purity against the published release specification of >99%, and mass spectrometry for identity. Only the second says which Semax variant is in the vial.

The Semax product page links the signed certificate for the shipping lot; the quality methodology explains each figure.

Common questions

What is Semax, in one line? A synthetic heptapeptide, Met-Glu-His-Phe-Pro-Gly-Pro (CAS 80714-61-0, C37H51N9O10S, MW 813.93), supplied as a lyophilised powder for research use only.

Is Semax the same thing as N-acetyl Semax? No — different molecules, roughly 42 Da apart. [5] The lot certificate’s mass-spectrometry data is what distinguishes them.

Why does the literature call it an ACTH(4-10) analogue when the sequence is ACTH(4-7)? Both descriptors appear in peer-reviewed papers for the same compound. ACTH(4-10) is Met-Glu-His-Phe-Arg-Trp-Gly; Semax is Met-Glu-His-Phe with Pro-Gly-Pro appended. Certificates should be read against the actual heptapeptide sequence.

Does a purity figure confirm identity? No. HPLC states how much of the material is one species; mass spectrometry states which one.

How is it stored? At −20°C, desiccated and protected from light.

Is this a medicine? No. It is research-use-only material, not for human or animal consumption.

References

  1. Dolotov OV, Karpenko EA, et al. Journal of Neurochemistry, 2006; 97 Suppl 1:82–86. PMID: 16635254. DOI: 10.1111/j.1471-4159.2006.03658.x — radioligand binding characterisation in rat basal forebrain membranes, with BDNF protein assayed in basal forebrain and cerebellum.
  2. Dolotov OV, Karpenko EA, et al. Brain Research, 2006; 1117(1):54–60. PMID: 16996037. DOI: 10.1016/j.brainres.2006.07.108 — BDNF and trkB transcript and protein measurements in rat hippocampus.
  3. Medvedeva EV, Dmitrieva VG, et al. BMC Genomics, 2014; 15:228. PMID: 24661604. DOI: 10.1186/1471-2164-15-228 — genome-wide microarray transcriptional profiling of rat cortex in a focal cerebral ischemia model.
  4. Filippenkov IB, Stavchansky VV, et al. Genes (Basel), 2020; 11(6):681. PMID: 32580520. DOI: 10.3390/genes11060681 — RNA-Seq transcriptome analysis of rat cortex in a transient middle cerebral artery occlusion model.
  5. Magrì A, Tabbì G, et al. Journal of Inorganic Biochemistry, 2016; 164:59–69. PMID: 27586814. DOI: 10.1016/j.jinorgbio.2016.08.013 — copper(II) and zinc(II) coordination chemistry of the free-amine and N-acetylated forms, characterised in solution and in an SH-SY5Y line.
  6. Eremin KO, Kudrin VS, et al. Neurochemical Research, 2005; 30(12):1493–1500. PMID: 16362768. DOI: 10.1007/s11064-005-8826-8 — dopamine, dopamine-metabolite and 5-HIAA concentrations measured in rodent striatum.

Published titles are not reproduced here. Each entry is identified by author, journal, year, PMID and DOI, followed by a neutral description of the model examined and the measurements taken. Those descriptions record what the papers measured in animal and cell models; they are not statements about use in people.


Related: How to verify a peptide certificate of analysis.

Semax (Met-Glu-His-Phe-Pro-Gly-Pro; ACTH(4-7)PGP), CAS 80714-61-0, C37H51N9O10S, MW 813.93. Release specification >99% by HPLC, identity confirmed by mass spectrometry — see the certificate for the shipping lot on the product page or in the public lot ledger. For research use only. Not for human or animal consumption. Not a drug.